Guardant Health, Inc.
GH
$129.69
-$3.53-2.65%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 39.56% | 32.88% | 30.38% | 28.74% | 28.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.56% | 32.88% | 30.38% | 28.74% | 28.20% |
| Cost of Revenue | 26.73% | 20.43% | 19.07% | 19.45% | 25.06% |
| Gross Profit | 47.65% | 40.91% | 37.82% | 34.95% | 30.27% |
| SG&A Expenses | 35.69% | 29.61% | 30.24% | 34.69% | 27.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.42% | 20.03% | 19.62% | 20.25% | 16.88% |
| Operating Income | 1.43% | 1.42% | -2.35% | -7.46% | -1.58% |
| Income Before Tax | -4.57% | 4.03% | 22.40% | 15.81% | 9.71% |
| Income Tax Expenses | -201.03% | -198.36% | 4,270.37% | 120.53% | 37.53% |
| Earnings from Continuing Operations | -4.00% | 4.61% | 22.17% | 15.68% | 9.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.00% | 4.61% | 22.17% | 15.68% | 9.62% |
| EBIT | 1.43% | 1.42% | -2.35% | -7.46% | -1.58% |
| EBITDA | 0.85% | 0.91% | -3.29% | -8.80% | -2.08% |
| EPS Basic | -0.63% | 6.77% | 24.16% | 18.24% | 13.87% |
| Normalized Basic EPS | 0.44% | -3.31% | -5.90% | -9.70% | 3.43% |
| EPS Diluted | -0.63% | 6.77% | 24.16% | 18.24% | 13.87% |
| Normalized Diluted EPS | 0.44% | -3.31% | -5.90% | -9.70% | 3.43% |
| Average Basic Shares Outstanding | 3.19% | 2.14% | 2.23% | 2.99% | 5.65% |
| Average Diluted Shares Outstanding | 3.19% | 2.14% | 2.23% | 2.99% | 5.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |